Key Takeaways
- Revenue hit by order deferrals, not losses: Total income fell 8.5% YoY as a few customers postponed orders and Bangladesh faced LC issuance issues, but the company retained every customer and product.
- Textiles rebounding, FMCG lagging: Textile volumes grew 20% and management declared the worst "already behind," while FMCG stayed muted on weak rural and urban demand, with a pickup expected in 1–2 quarters.
- New verticals are tiny but moving fast: Drilling revenue jumped nearly 30x YoY off a small base, and the bio-based AquaStrike mosquito control launch opens a government-funded, thousands-of-crores market with no known direct competitor.
- Margins held firm through the soft patch: EBITDA margin stayed at 27.2% and gross margin at 41%, both stable or better QoQ, while the company continued investing in capacity, products and an acquisition pipeline.
- What to watch next quarter: Whether the postponed orders convert into a March-quarter bounce, the pace of Bangladesh export recovery, and any concrete update on the advanced-stage acquisition now in due diligence.
Demand & Segment Performance
- Textile: recovery underway. Volumes rose 20%, revenue up 12% broadly, and the company exhibited at Bharat Tex to "unbelievable" foreign buyer interest. Bangladesh disruptions are called short-term; an office and team are already in place there, with plans to hire more.
- FMCG: waiting on the consumer. Muted growth reflected weak rural and urban demand through December. Management expects the budget's tax measures and summer season cleaning demand to lift consumption, with rural already picking up and urban following in 1–2 quarters.
- Export share compressed by Bangladesh. Exports fell to 19% of revenue from 24%, driven entirely by political and social turmoil disrupting letters of credit. Management is hopeful the uncertainty fades soon and notes better performance already emerging in the current quarter.
- Customer base intact and growing. No customer or product was lost in the last nine months; 30 new textile customers were added in Q3 alone.
Sanjay Tibrewala: "Definitely. In textiles, the worst is already behind for us. I would rather say not only for textiles, I think even for the FMCG with the new the taxation norms, which is helping the demand of urban and also rural demands to go up."
New Verticals & Product Launches
- Oil & gas and water treatment gaining traction. Strong order pipelines are building across both segments, supported by upstream activity, offshore exploration, shale gas, and tightening zero-liquid-discharge and desalination policies.
- Drilling chemicals: 30x growth from a tiny base. Management calls these sustainable businesses with high entry and exit barriers once established. The company is tying up with large US firms that have a mandate to expand India sourcing by 5x amid the China geopolitical shift.
- AquaStrike Premium: a bio-based mosquito control with no known competitor. The product is non-toxic, safe for drinking water, and also preserves water from evaporation. It replaces crude-oil-based alternatives. The go-to-market targets foundations (e.g., Bill Gates Foundation) that finance distribution in epidemic-affected regions like Africa. Market size is estimated in the thousands of crores.
- 30 new products developed during the quarter, with 15 more added, underscoring a deliberate diversification push.
Sanjay Tibrewala: "We are talking to and speaking to all these big U.S. companies, they have a simple mandate that they have to expand their purchases and sourcing from India by 5x."
Margins & Operational Efficiency
- EBITDA margin held at 27.2% despite the revenue decline, with gross margins at 41% and both metrics stable or better on a QoQ basis. Management does not view this as a decline.
- Total volume down ~5% due to slight pricing pressure and orders postponed but not yet reflected in revenue.
- Capacity expansion designed to lift efficiency. Shifting lines from Mahape to the new Ambernath plant will improve economies of scale, lower operating costs through better technology, ease logistics bottlenecks, and enable larger production batches. Phase 1 (15,000 tonnes) is expected to start by July–September.
- Sustainability investments are operational now. A 100-kilowatt solar plant is running at Ambernath, and manufacturing processes achieved ZDHC certification for zero hazardous chemical discharge. Management frames sustainability as the defining theme for specialty chemical companies going forward.
Sanjay Tibrewala: "If you see our growth for the last 13 years of being listed or 14 years of being listed, we have a CAGR of 28%. In any of the quarter, you will not find our EBITDA below 17% over the 54 quarters of being listed."
Capital Allocation & M&A
- Acquisition in advanced due diligence. The company confirmed discussions are at an advanced stage, disclosed on the stock exchange, but declined to provide a timeline or confirm whether the specific foreign deal is still on track.
- Discipline is the stated mantra. Any deal must be EPS-accretive and not expensive. Management pointed to examples of other chemical companies that raised funds, bought assets, and are now "not faring well," vowing not to repeat that outcome. A war chest of over ₹300 crores is earmarked for inorganic moves.
- Preferential warrant inflow ahead. The remaining 75% (approximately ₹150 crores) of the preferential raise, structured as a mix of equity and warrants, is due by October/November.
Sanjay Tibrewala: "We will not be doing anything for the heck of like other chemical companies, most of us know examples, which a lot of funds have been raised, certain chemical companies have been bought and not faring well. We do not want to have a sorry figure at the end of it."
Strategic Positioning
- Sustainability as a moat. The company is an early mover with ZDHC certification and bio-based products. Large FMCG customers like Unilever and P&G have committed to going fully sustainable by 2027–28, and Fineotex is positioned to capture that shift.
- US sourcing shift from China is a tailwind. Big US companies have a mandate to expand India purchases by 5x, and Fineotex is in active discussions with them across its drilling and oil & gas portfolio.
- India textile story intact. Management believes India will be "definitely shining" in textiles going forward, with the Bangladesh disruption a short-term fluctuation that does not alter the structural opportunity.
- Long-term consistency is the pitch. The company points to a 28% revenue CAGR over 13–14 listed years and EBITDA never dipping below 17% in any of 54 quarters, framing the current softness as a blip in a long compounding story.
Sanjay Tibrewala: "Sustainability will be the key for any manufacturing specialty chemical companies going forward. Everything is beginning and ending with sustainability..."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| New plant operational | Phase 1 adding 15,000 tonnes capacity | Q2 FY26 (July–September 2025) |
| Preferential warrant inflow | Remaining ~₹150 crores received | By October/November 2025 |
| FMCG demand pickup | Urban demand to gradually improve, aided by budget tax measures and summer season | 1–2 quarters |
| Bangladesh export recovery | Political uncertainty expected to fade; better performance already visible in current quarter | "Very soon" / current quarter |
| Acquisition update | Any deal will be EPS-accretive and not expensive; update via stock exchange when concrete | No timeline given |
Key Metrics
| Metric | Q3 FY25 |
|---|---|
| Total income | ₹131 cr, decline of 8.5% YoY |
| EBITDA margin | 27.2%, healthy despite external pressures |
| Gross margin | 41%, slightly higher |
| Revenue CAGR since 2020 | 30.5% (consolidated) |
| Profit CAGR since 2020 | 70.5% |
| Export share (9M FY25) | 19%, down from 24% in same period last year |
| Textile revenue growth | +12% broadly YoY |
| Textile volume growth | +20% YoY |
| Total volume change | Down ~4-5% YoY |
| Revenue split: Textile | 78% of Q3 revenue |
| Revenue split: FMCG and others | 23% of Q3 revenue |
| New customers added (textile) | 30 in Q3 |
| New products developed | 30 in Q3 |
| Cash on books | ~₹350 cr |
| Earmarked fund for inorganic strategy | Over ₹300 cr |
| Drilling business growth | Up ~30x YoY |